Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Free Cash Flow (2018 - 2026)

DiaMedica Therapeutics filings provide 9 years of Free Cash Flow readings, the most recent being -$9.1 million for Q1 2026.

  • Quarterly Free Cash Flow fell 27.19% to -$9.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$31.0 million through Mar 2026, down 37.38% year-over-year, with the annual reading at -$29.1 million for FY2025, 31.68% down from the prior year.
  • Free Cash Flow hit -$9.1 million in Q1 2026 for DiaMedica Therapeutics, down from -$7.8 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$2.4 million in Q3 2022 and bottomed at -$9.1 million in Q1 2026.
  • Average Free Cash Flow over 5 years is -$5.3 million, with a median of -$5.0 million recorded in 2023.
  • The largest annual shift saw Free Cash Flow grew 21.13% in 2022 before it tumbled 101.2% in 2023.
  • DiaMedica Therapeutics' Free Cash Flow stood at -$2.8 million in 2022, then tumbled by 36.35% to -$3.8 million in 2023, then crashed by 68.83% to -$6.4 million in 2024, then decreased by 20.6% to -$7.8 million in 2025, then dropped by 17.25% to -$9.1 million in 2026.
  • Per Business Quant, the three most recent readings for DMAC's Free Cash Flow are -$9.1 million (Q1 2026), -$7.8 million (Q4 2025), and -$6.6 million (Q3 2025).